SANDRA COX: Open Payments
NPI 1447541883 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 21 payments from 12 companies in 2025. Trend: 2023 $1,265 · 2024 $21 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 2 | $337 |
| GlaxoSmithKline, LLC. | 6 | $135 |
| ABBVIE INC. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Aveo Pharmaceuticals, Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| TAIHO ONCOLOGY, INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $20 |
Products named: Optune Lua (NovoTTF-200T), OJJAARA, LUTATHERA, FOTIVDA, VENCLEXTA, DATROWAY, JEMPERLI, LONSURF.
Industry payments across MO — which companies pay providers there.
